World's Best Scientists 2026 revealed!
Federico Caligaris-Cappio

Federico Caligaris-Cappio

D-Index & Metrics

Medicine

D-Index
82
Citations
31384
World Ranking
15931
National Ranking
625

Overview

Federico Caligaris-Cappio is affiliated with Vita-Salute San Raffaele University in Italy. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with an emphasis on Immunology, Genetics, and Oncology as key subfields.

The scientist's work centers on several major topics including Immune Cell Function and Interaction, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, and Galectins and Cancer Biology. These topics are reflected across their recent academic output.

Recent papers authored or co-authored by Federico Caligaris-Cappio include:

  • Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia, 2022, Leukemia & lymphoma/Leukemia and lymphoma
  • The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia, 2024, Blood Cancer Journal
  • Dataset related to article "IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development.", 2020, Zenodo (CERN European Organization for Nuclear Research)
  • Dataset related to article "IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development.", 2020, Zenodo (CERN European Organization for Nuclear Research)

Frequent co-authors in their work include Maurilio Ponzoni, Federica Barbaglio, William G. Wierda, Varsha Gandhi, and Paolo Ghia.

Federico Caligaris-Cappio's publications have appeared notably in the venues Zenodo (CERN European Organization for Nuclear Research), Leukemia & lymphoma/Leukemia and lymphoma, and Blood Cancer Journal, indicating a blend of data-sharing platforms and peer-reviewed specialized journals.

Best Publications

  • Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

    Michael Hallek;K. Fischer;Gunter Fingerle-Rowson;A.M. Fink

  • Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

    J. C. Byrd;J. R. Brown;Susan O'Brien;J. C. Barrientos

  • iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

    Andrés J. M. Ferreri;Michele Reni;Marco Foppoli;Maurizio Martelli

  • The microenvironment in mature B-cell malignancies: a target for new treatment strategies

    Jan A. Burger;Paolo Ghia;Andreas Rosenwald;Federico Caligaris-Cappio

  • Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

    Luisa Granziero;Paolo Ghia;Paola Circosta;Daniela Gottardi

  • Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations

    Kostas Stamatopoulos;Chrysoula Belessi;Carol Moreno;Myriam Boudjograh

  • Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.

    Federico Caligaris-Cappio;Marco Gobbi;Margarita Bofill;George Janossy

  • B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather

    Federico Caligaris-Cappio;Terry J. Hamblin

  • Chronic lymphocytic leukemia : revelations from the B-cell receptor

    Freda K. Stevenson;Federico Caligaris-Cappio

  • International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

    A C Rawstron;N Villamor;M Ritgen;S Böttcher

  • Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis

    Fiona Murray;Nikos Darzentas;Anastasia Hadzidimitriou;Gerard Tobin

  • Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

    Paolo Ghia;Giuliana Strola;Luisa Granziero;Massimo Geuna

  • MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation

    Alessandra Stacchini;Michela Aragno;Antonella Vallario;Alda Alfarano

  • The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.

    Paolo Ghia;Giuseppe Guida;Stefania Stella;Daniela Gottardi

  • Role of bone marrow stromal cells in the growth of human multiple myeloma.

    Federico Caligaris-Cappio;Luciana Bergui;Maria Grazia Gregoretti;Gianluca Gaidano

  • Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers

    Francesca Cottini;Teru Hideshima;Chunxiao Xu;Martin Sattler

  • B-chronic lymphocytic leukemia: a malignancy of anti-self B cells.

    Federico Caligaris-Cappio

  • Role of the microenvironment in chronic lymphocytic leukaemia

    Federico Caligaris-Cappio

Frequent Co-Authors

Paolo Ghia
Paolo Ghia Vita-Salute San Raffaele University
Marta Muzio
Marta Muzio Vita-Salute San Raffaele University
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Claudio Bordignon
Claudio Bordignon MolMed (Italy)
Emili Montserrat
Emili Montserrat University of Barcelona
Kostas Stamatopoulos
Kostas Stamatopoulos Centre for Research and Technology Hellas
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
Thomas J. Kipps
Thomas J. Kipps University of California, San Diego
Daniel Catovsky
Daniel Catovsky Institute of Cancer Research
Bruce D. Cheson
Bruce D. Cheson Georgetown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is just one option in a vast landscape of health-related careers. Prospective students can explore many flexible degree paths online, which cater to different interests and schedules. For those interested in patient care but looking for streamlined admission processes, nursing school no entrance exam options are becoming more popular, eliminating barriers like standardized test requirements.

If you see yourself managing healthcare facilities rather than providing clinical care, consider enrolling in a healthcare administration associate degree online. These programs prepare students to take on administrative roles in hospitals and clinics.

Registered nurses aiming to advance their careers can look into the adn to fnp bridge programs, which allow you to become a Family Nurse Practitioner through an accelerated path. Meanwhile, students interested in preventative care and holistic health may pursue a nutrition degree online, opening doors to roles in dietary counseling, education, and wellness coaching.

Each of these online options provides flexible, career-focused pathways to becoming a key part of the healthcare sector—without the traditional barriers of on-campus learning.

Best Scientists Citing Federico Caligaris-Cappio

Trending Scientists

Recently Published Articles